Sign in

CIK 0001404644

  • Non-accelerated filer
  • Smaller reporting company

Neurogene Inc.

Sign in to watch
Ticker
NGNE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
980542593
Phone
+1 877-237-5020
Business address
535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
Former names
Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 38 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-04-02 Redmile Group, LLC 10% owner Purchase +38,300 $11.36 $435K 4,050,045
2020-04-02 Redmile Group, LLC 10% owner Purchase +1,000 $11.85 $12K 4,051,045
2020-04-02 Redmile Group, LLC 10% owner Sale −9,734 $11.30 $110K 4,041,311
2020-04-02 Redmile Group, LLC 10% owner Sale −100 $11.82 $1K 4,041,211
2020-04-01 Redmile Group, LLC 10% owner Purchase +33,500 $10.95 $367K 4,012,579
2020-04-01 Redmile Group, LLC 10% owner Purchase +9,000 $11.65 $105K 4,021,579
2020-04-01 Redmile Group, LLC 10% owner Sale −9,634 $11.06 $107K 4,011,945
2020-04-01 Redmile Group, LLC 10% owner Sale −200 $11.87 $2K 4,011,745
2020-03-31 Redmile Group, LLC 10% owner Purchase +22,500 $10.18 $229K 3,971,579
2020-03-31 Redmile Group, LLC 10% owner Purchase +7,500 $10.71 $80K 3,979,079
2020-03-30 Redmile Group, LLC 10% owner Purchase +29,800 $9.91 $295K 3,946,379
2020-03-30 Redmile Group, LLC 10% owner Purchase +2,700 $10.27 $28K 3,949,079
2020-03-27 Redmile Group, LLC 10% owner Purchase +50,000 $9.21 $460K 3,916,579
2020-03-16 Ho Robert Chief Financial Officer Grant or award · Restricted Stock Units +75,000 75,000
2020-03-16 Ho Robert Chief Financial Officer Grant or award · Stock Option (Right to Buy) +200,000 200,000
2019-12-20 BAKER BROS. ADVISORS LP Director Purchase +250,037 $8.40 $2.1M 1,450,557
2019-12-20 BAKER BROS. ADVISORS LP Director Purchase +2,767,505 $8.40 $23.2M 12,872,664
2019-12-20 BAKER BROS. ADVISORS LP Director Returned to the company −1,160,148 290,409
2019-12-20 BAKER BROS. ADVISORS LP Director Returned to the company −9,765,333 3,107,331
2019-12-20 BAKER BROS. ADVISORS LP Director Grant or award · Pre-funded Warrants +1,160,148 1,161,048

Page 11 of 20 · 397 trades